Home / Temozolomide / Italy
IT ATC L01AX03 · updated 2 Nov 2026
Temozolomide shortage in Italy
Is there a Temozolomide shortage in Italy?
Yes. As of 2 Nov 2026, 11 Temozolomide products are reported short in Italy, the first since 6 Nov 2025. The company estimate for the return is 31 Jan 2027 (latest 28 Feb 2027). Main reason: manufacturing problem.
Also short in Canada, Spain, Ireland, Sweden, Australia. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | TEMOZOLOMIDE ACCORD discontinuation | ACCORD HEALTHCARE, S.L.U. | 6 Nov 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | TEMOZOLOMIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 13 Feb 2026 | not given | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | TEMOZOLOMIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 13 Feb 2026 | not given | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | TEMOZOLOMIDE TEVA | TEVA B.V. | 1 Apr 2026 | 28 Feb 2027 | Manufacturing problem Problemi produttivi (carenza relativa solo al canale ospedaliero) |
| IT | TEMOZOLOMIDE ACCORD | ACCORD HEALTHCARE, S.L.U. | 31 Aug 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | TEMOZOLOMIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 4 Sep 2026 | not given | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | TEMOZOLOMIDE ACCORD | ACCORD HEALTHCARE, S.L.U. | 1 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | TEMOZOLOMIDE ACCORD | ACCORD HEALTHCARE, S.L.U. | 1 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | TEMOZOLOMIDE SUN discontinuation | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 5 Oct 2026 | not given | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | TEMOZOLOMIDE TEVA | TEVA B.V. | 2 Nov 2026 | 31 Jan 2027 | Manufacturing problem Problemi produttivi (carenza relativa solo al canale retail) |
| IT | TEMOZOLOMIDE TEVA anticipated | TEVA B.V. | 23 Nov 2026 | 28 Feb 2027 | Manufacturing problem Problemi produttivi (carenza relativa solo al canale ospedaliero) |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.